BRAINSWAY LTD-ADR (BWAY) Fundamental Analysis & Valuation

NASDAQ:BWAY • US10501L1061

Current stock price

13.49 USD
0 (0%)
Last:

This BWAY fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. BWAY Profitability Analysis

1.1 Basic Checks

  • BWAY had positive earnings in the past year.
  • BWAY had a positive operating cash flow in the past year.
  • In the past 5 years BWAY reported 4 times negative net income.
  • The reported operating cash flow has been mixed in the past 5 years: BWAY reported negative operating cash flow in multiple years.
BWAY Yearly Net Income VS EBIT VS OCF VS FCFBWAY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

1.2 Ratios

  • The Return On Assets of BWAY (5.53%) is better than 81.48% of its industry peers.
  • With an excellent Return On Equity value of 8.92%, BWAY belongs to the best of the industry, outperforming 81.48% of the companies in the same industry.
  • BWAY has a better Return On Invested Capital (2.75%) than 70.90% of its industry peers.
Industry RankSector Rank
ROA 5.53%
ROE 8.92%
ROIC 2.75%
ROA(3y)-8.09%
ROA(5y)-9.73%
ROE(3y)-11.6%
ROE(5y)-14.71%
ROIC(3y)N/A
ROIC(5y)N/A
BWAY Yearly ROA, ROE, ROICBWAY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

  • Looking at the Profit Margin, with a value of 12.73%, BWAY belongs to the top of the industry, outperforming 86.77% of the companies in the same industry.
  • Looking at the Operating Margin, with a value of 5.78%, BWAY is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
  • BWAY's Gross Margin of 74.92% is amongst the best of the industry. BWAY outperforms 85.19% of its industry peers.
  • BWAY's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.78%
PM (TTM) 12.73%
GM 74.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.39%
GM growth 5Y-0.85%
BWAY Yearly Profit, Operating, Gross MarginsBWAY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. BWAY Health Analysis

2.1 Basic Checks

  • BWAY has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • There is no outstanding debt for BWAY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BWAY Yearly Shares OutstandingBWAY Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
BWAY Yearly Total Debt VS Total AssetsBWAY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • An Altman-Z score of 3.72 indicates that BWAY is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 3.72, BWAY is in the better half of the industry, outperforming 72.49% of the companies in the same industry.
  • The Debt to FCF ratio of BWAY is 0.37, which is an excellent value as it means it would take BWAY, only 0.37 years of fcf income to pay off all of its debts.
  • With an excellent Debt to FCF ratio value of 0.37, BWAY belongs to the best of the industry, outperforming 92.06% of the companies in the same industry.
  • BWAY has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
  • BWAY has a better Debt to Equity ratio (0.08) than 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.37
Altman-Z 3.72
ROIC/WACC0.32
WACC8.47%
BWAY Yearly LT Debt VS Equity VS FCFBWAY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

  • A Current Ratio of 3.19 indicates that BWAY has no problem at all paying its short term obligations.
  • BWAY's Current ratio of 3.19 is in line compared to the rest of the industry. BWAY outperforms 57.14% of its industry peers.
  • A Quick Ratio of 3.02 indicates that BWAY has no problem at all paying its short term obligations.
  • BWAY's Quick ratio of 3.02 is fine compared to the rest of the industry. BWAY outperforms 65.08% of its industry peers.
Industry RankSector Rank
Current Ratio 3.19
Quick Ratio 3.02
BWAY Yearly Current Assets VS Current LiabilitesBWAY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. BWAY Growth Analysis

3.1 Past

  • BWAY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 117.91%, which is quite impressive.
EPS 1Y (TTM)117.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.68%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%11.8%

3.2 Future

  • The Earnings Per Share is expected to grow by 29.61% on average over the next years. This is a very strong growth
  • BWAY is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 23.85% yearly.
EPS Next Y-3.28%
EPS Next 2Y29.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year23.37%
Revenue Next 2Y23.85%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

BWAY Yearly Revenue VS EstimatesBWAY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
BWAY Yearly EPS VS EstimatesBWAY Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2 -2

More info and screens

Find the best growth stocksShow best growing peers

7

4. BWAY Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 10.46 indicates a reasonable valuation of BWAY.
  • 92.59% of the companies in the same industry are more expensive than BWAY, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 25.23. BWAY is valued rather cheaply when compared to this.
  • BWAY is valuated reasonably with a Price/Forward Earnings ratio of 10.83.
  • 92.06% of the companies in the same industry are more expensive than BWAY, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of BWAY to the average of the S&P500 Index (22.51), we can say BWAY is valued rather cheaply.
Industry RankSector Rank
PE 10.46
Fwd PE 10.83
BWAY Price Earnings VS Forward Price EarningsBWAY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • BWAY's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. BWAY is cheaper than 67.72% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, BWAY is valued cheaply inside the industry as 96.30% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 14.42
EV/EBITDA 41.99
BWAY Per share dataBWAY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

  • BWAY's earnings are expected to grow with 29.61% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.61%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BWAY Dividend Analysis

5.1 Amount

  • BWAY does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BWAY Fundamentals: All Metrics, Ratios and Statistics

BRAINSWAY LTD-ADR

NASDAQ:BWAY (3/27/2026, 10:55:02 AM)

13.49

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-11
Earnings (Next)05-11
Inst Owners5.36%
Inst Owner Change10.06%
Ins Owners15.48%
Ins Owner Change0%
Market Cap264.56M
Revenue(TTM)N/A
Net Income(TTM)6.25M
Analysts85.71
Price TargetN/A
Short Float %N/A
Short Ratio0.79
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)65.34%
Min EPS beat(2)35.56%
Max EPS beat(2)95.12%
EPS beat(4)3
Avg EPS beat(4)50.32%
Min EPS beat(4)-22.64%
Max EPS beat(4)95.12%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.57%
Min Revenue beat(2)-1.07%
Max Revenue beat(2)-0.08%
Revenue beat(4)1
Avg Revenue beat(4)-0.87%
Min Revenue beat(4)-2.35%
Max Revenue beat(4)0.01%
Revenue beat(8)4
Avg Revenue beat(8)-0.3%
Revenue beat(12)6
Avg Revenue beat(12)-11.32%
Revenue beat(16)6
Avg Revenue beat(16)-26.49%
PT rev (1m)0%
PT rev (3m)3.66%
EPS NQ rev (1m)-0.02%
EPS NQ rev (3m)-6.51%
EPS NY rev (1m)-0.02%
EPS NY rev (3m)5.03%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.81%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.87%
Valuation
Industry RankSector Rank
PE 10.46
Fwd PE 10.83
P/S 5.39
P/FCF 14.42
P/OCF 11.88
P/B 3.78
P/tB 3.78
EV/EBITDA 41.99
EPS(TTM)1.29
EY9.56%
EPS(NY)1.25
Fwd EY9.23%
FCF(TTM)0.94
FCFY6.93%
OCF(TTM)1.14
OCFY8.42%
SpS2.5
BVpS3.57
TBVpS3.57
PEG (NY)N/A
PEG (5Y)N/A
Graham Number10.18
Profitability
Industry RankSector Rank
ROA 5.53%
ROE 8.92%
ROCE 3.26%
ROIC 2.75%
ROICexc 15.43%
ROICexgc 15.43%
OM 5.78%
PM (TTM) 12.73%
GM 74.92%
FCFM 37.36%
ROA(3y)-8.09%
ROA(5y)-9.73%
ROE(3y)-11.6%
ROE(5y)-14.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.39%
GM growth 5Y-0.85%
F-Score5
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.37
Debt/EBITDA 1.21
Cap/Depr 207.6%
Cap/Sales 8.01%
Interest Coverage 26.28
Cash Conversion 470.69%
Profit Quality 293.55%
Current Ratio 3.19
Quick Ratio 3.02
Altman-Z 3.72
F-Score5
WACC8.47%
ROIC/WACC0.32
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)117.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.68%
EPS Next Y-3.28%
EPS Next 2Y29.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%11.8%
Revenue Next Year23.37%
Revenue Next 2Y23.85%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y147.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year6.54%
EBIT Next 3Y43.13%
EBIT Next 5YN/A
FCF growth 1Y441.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y749.36%
OCF growth 3Y127.03%
OCF growth 5YN/A

BRAINSWAY LTD-ADR / BWAY Fundamental Analysis FAQ

What is the fundamental rating for BWAY stock?

ChartMill assigns a fundamental rating of 5 / 10 to BWAY.


Can you provide the valuation status for BRAINSWAY LTD-ADR?

ChartMill assigns a valuation rating of 7 / 10 to BRAINSWAY LTD-ADR (BWAY). This can be considered as Undervalued.


How profitable is BRAINSWAY LTD-ADR (BWAY) stock?

BRAINSWAY LTD-ADR (BWAY) has a profitability rating of 5 / 10.


Can you provide the expected EPS growth for BWAY stock?

The Earnings per Share (EPS) of BRAINSWAY LTD-ADR (BWAY) is expected to decline by -3.28% in the next year.